FIGUR8, Inc.

FIGUR8, Inc. develops FDA-registered musculoskeletal (MSK) assessment technology that replaces subjective measurement tools with objective, lab-grade biomechanics data. The company's flagship platform, the bioMotion Assessment Platform (bMAP), combines on-body wearable sensors with cloud-based analytics to provide precise movement analysis and functional capacity assessments. FIGUR8 serves physical therapists, orthopedic surgeons, chiropractors, occupational health clinics, workers' compensation payers, and sports medicine practitioners. The platform captures over one million data points during dynamic functional movement testing, offering quantitative metrics for injury assessment, recovery monitoring, and return-to-work determination. Use cases include workers' compensation claim management, surgical candidacy evaluation, post-injury rehabilitation tracking, and athletic performance assessment. FIGUR8 is particularly positioned for workers' compensation and occupational health markets, where objective MSK data reduces claim duration and improves outcomes. The company emphasizes clinical training and provider enablement through didactic courses and onsite support. Regulatory status includes FDA registration; the site references compliance with clinical standards and the APTA Digital Transparency Pledge. The technology addresses a significant clinical gap by providing consistent, repeatable objective metrics superior to manual muscle testing and traditional subjective clinical assessments.